← All trials
NCT01265563
Phase 2Interventional
Includes controlled clinical studies conducted to evaluate the effectiveness of the drug for a particular indication or indications in participants with the disease or condition under study and to determine the common short-term side effects and risks.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jan 1, 2011
- Primary completion
- Feb 1, 2015
- Completion date
- Dec 1, 2016
- First posted
- —
- Last posted
- —
- Enrollment
- 108
- Arms / groups
- 5 / —
- Source
- AACT · pre-existing
Sponsors
- Department of Veteran AffairsLead sponsor
- South Texas Health Care System, San Antonio, TXOverall official - principal investigator
- National Center for Complementary and Integrative Health (NCCIH)Collaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.